• Eicosapentaenoic Acid: Protocols and Innovations in Cardiova

  2026-06-28

  Eicosapentaenoic Acid (EPA) stands out as a rigorously characterized omega-3 fatty acid, enabling reproducible and advanced cardiovascular and immunomodulation studies. This article unpacks workflow optimizations, protocol enhancements, and troubleshooting strategies, clarifying EPA’s applied advantages and cross-domain potential.

• Acetylspiramycin Workflows: Advancing Antimicrobial Resistan

  2026-06-27

  Acetylspiramycin (Spiramycin B) enables precise benchmarking of macrolide efficacy in resistant Mycoplasma pneumoniae and Gram-positive models. Its dual action as a ribosomal inhibitor and immune modulator positions it as an essential tool for next-generation host-pathogen interaction studies.

• CHK1 Inhibition in Breast Cancer: ER/PR Status-Dependent Eff

  2026-06-26

  This study elucidates how the effectiveness of CHK1 inhibition in breast cancer is modulated by estrogen and progesterone receptor status, with distinct mechanisms underlying chemosensitization and single-agent activity. These insights provide a framework for more precise application of molecular targeted therapies in context of tumor heterogeneity.

• Protease Inhibitor Cocktail: Precision Safeguard for Protein

  2026-06-26

  Unlock robust protein extraction and phosphorylation studies with the Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO). Its unique EDTA-free composition ensures compatibility with cation-sensitive assays while delivering broad-spectrum protection against proteolysis, especially in workflows targeting post-translational modifications.

• Adipose-Neural Axis Drives Arrhythmia via Leptin-NPY Pathway

  2026-06-25

  Fan et al. (2024) demonstrate that the interplay between epicardial adipose tissue and the sympathetic nervous system, mediated by the leptin–NPY–Y1R axis, is a key driver of cardiac arrhythmias. Their innovative human stem cell-based coculture model provides new molecular targets and an advanced experimental platform for mechanistic arrhythmia research.

• Lypressin Acetate: Bridging Antidiuretic and Antiviral Innov

  2026-06-25

  Explore how Lypressin acetate advances both antidiuretic research and antiviral assay development. This article delivers a unique, mechanistic perspective on lysine vasopressin acetate, with actionable protocols and cross-domain insights.

• Dacarbazine: Applied Workflows and Troubleshooting in Oncolo

  2026-06-24

  Dacarbazine is a cornerstone antineoplastic chemotherapy drug for malignant melanoma, Hodgkin lymphoma, and sarcoma models. This guide delivers actionable protocols, troubleshooting strategies, and evidence-driven workflow enhancements—empowering cancer researchers to maximize experimental reproducibility and interpret DNA damage assays with confidence.

• Staurosporine in Metastasis Modeling: Unveiling Apoptosis-Dr

  2026-06-23

  Explore how Staurosporine, a broad-spectrum serine/threonine protein kinase inhibitor, uniquely enables advanced modeling of apoptosis-induced metastasis in cancer research. This article reveals mechanistic links between kinase inhibition, cell death, and pro-metastatic state induction—extending beyond standard apoptosis assays.

• Nanoparticle-Mediated mRNA Reverses Trastuzumab Resistance i

  2026-06-23

  This study introduces a tumor microenvironment-responsive nanoparticle system for systemic delivery of PTEN mRNA, targeting the PI3K/Akt pathway to overcome trastuzumab resistance in HER2-positive breast cancer. The findings highlight a promising approach for restoring tumor suppressor function and improving monoclonal antibody therapy outcomes.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-06-22

  This study demonstrates that tumor microenvironment-responsive nanoparticles can systemically deliver PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN and inhibiting PI3K/Akt signaling, the approach offers a promising precision strategy for resistant cancer phenotypes.

• Ribonuclease R (20 U/μL): Streamlining Circular RNA Enrichme

  2026-06-22

  Ribonuclease R (RNase R) (20 U/μL) from APExBIO transforms circular RNA research by delivering highly selective linear RNA digestion, critical for advanced RNA structure-function and inflammation studies. Explore optimized workflows, troubleshooting strategies, and the translational impact of RNase R in dissecting complex RNA-mediated pathways.

• Synthetic Modified mRNA Enables Rapid hiPSC-to-Oligodendrocy

  2026-06-21

  The referenced study demonstrates a non-viral, synthetic modified mRNA (smRNA) approach for efficiently differentiating human-induced pluripotent stem cells (hiPSCs) into functional oligodendrocytes. By using OLIG2 S147A smRNA, the protocol achieves high-purity oligodendrocyte progenitor cells in six days, offering a safer and faster alternative to traditional methods for cell therapy and disease modeling.

• DFCP1 Modulates Starvation-Driven Lipid Droplet Lipolysis vi

  2026-06-20

  The reference study identifies DFCP1 as a nutrient-sensitive regulator of lipid droplet metabolism, acting through direct modulation of ATGL-mediated lipolysis during starvation. These insights clarify key molecular mechanisms in lipid mobilization and have implications for metabolic disease research and advanced protein stability workflows.

• Sodium Ascorbate: From Molecular Mechanism to Oncology Model

  2026-06-19

  Explore the advanced mechanistic role of sodium ascorbate, a mineral salt of ascorbic acid, in precise oncology research. This in-depth analysis reveals how nuanced ROS modulation and necrotic tumor cell death inform the next generation of glioblastoma and immunotherapy modeling.

• SIRT1-Regulated Ran Lactylation Drives Astrocyte Polarizatio

  2026-06-19

  This study uncovers a novel mechanism in which lactate-induced lactylation of the small GTPase Ran at lysine 123, regulated by SIRT1, enables astrocyte polarization following oxygen-glucose deprivation/reoxygenation (OGD/R). These findings highlight the importance of non-histone protein lactylation in central nervous system injury repair, offering new molecular targets for therapeutic intervention.

11461 records 1/765 page Next 12345 下5页 Last page